BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+49.08%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$18.8B
AUM Growth
+$18.8B
(+28%)
Cap. Flow
-$433M
Cap. Flow
% of AUM
-2.3%
Top 10 Holdings %
Top 10 Hldgs %
85.02%
Holding
117
New
8
Increased
21
Reduced
10
Closed
18
Top Buys
| 1 |
Exact Sciences
EXAS
|
$239M |
| 2 |
Kodiak Sciences
KOD
|
$137M |
| 3 |
DBVT
DBV Technologies
DBVT
|
$97.4M |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
$34.5M |
| 5 |
Korro Bio
KRRO
|
$21.6M |
Top Sells
| 1 |
GHDX
Genomic Health, Inc.
GHDX
|
$627M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$151M |
| 3 |
Neurogene
NGNE
|
$97.4M |
| 4 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$72.9M |
| 5 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$42M |
Sector Composition
| 1 | Healthcare | 98.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$30.3B
| $58.4M | 0.31% |
2,445,265
+215,505
| +10% | +$5.15M |
|
27
Krystal Biotech
KRYS
$4.35B
| $57.3M | 0.3% |
1,034,674
| – | – |
|
|
BCEL
28
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $54.7M | 0.29% |
3,532,760
| – | – |
|
|
BOLD
29
DELISTED
Audentes Therapeutics, Inc
BOLD
| $48.2M | 0.26% |
804,720
-701,718
| -47% | -$42M |
|
30
Cerus
CERS
$251M
| $45.4M | 0.24% |
10,749,937
| – | – |
|
|
31
Neurogene
NGNE
$284M
| $41.9M | 0.22% |
3,397,740
-7,907,939
| -70% | -$97.4M |
|
|
GWPH
32
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $38.8M | 0.21% |
370,845
| – | – |
|
33
BioCryst Pharmaceuticals
BCRX
$1.74B
| $37.8M | 0.2% |
10,946,166
-1,779,306
| -14% | -$6.14M |
|
34
uniQure
QURE
$954M
| $37.1M | 0.2% |
517,700
| – | – |
|
|
35
Aurinia Pharmaceuticals
AUPH
$1.58B
| $34.5M | 0.18% |
+1,701,929
| New | +$34.5M |
|
36
Adaptive Biotechnologies
ADPT
$1.96B
| $33.4M | 0.18% |
1,115,411
-50,000
| -4% | -$1.5M |
|
|
ALLK
37
DELISTED
Allakos
ALLK
| $32.4M | 0.17% |
339,690
| – | – |
|
38
Assembly Biosciences
ASMB
$183M
| $31.5M | 0.17% |
1,541,618
+738,372
| +92% | +$15.1M |
|
39
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $31M | 0.16% |
2,799,577
| – | – |
|
|
CCXI
40
DELISTED
ChemoCentryx, Inc.
CCXI
| $29.2M | 0.16% |
739,016
+531,987
| +257% | +$21M |
|
41
Merus
MRUS
$5.04B
| $28.7M | 0.15% |
2,037,469
+877,455
| +76% | +$12.4M |
|
42
UroGen Pharma
URGN
$896M
| $27.7M | 0.15% |
831,488
+83,737
| +11% | +$2.79M |
|
|
AIMT
43
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $22.6M | 0.12% |
673,908
| – | – |
|
|
44
Korro Bio
KRRO
$245M
| $21.6M | 0.11% |
+1,231,433
| New | +$21.6M |
|
45
Alkermes
ALKS
$4.95B
| $16.2M | 0.09% |
793,130
+168,100
| +27% | +$3.43M |
|
|
UROV
46
DELISTED
Urovant Sciences Ltd.
UROV
| $15.5M | 0.08% |
+1,000,000
| New | +$15.5M |
|
47
Apellis Pharmaceuticals
APLS
$3.51B
| $15.2M | 0.08% |
496,969
+183,244
| +58% | +$5.61M |
|
48
Xencor
XNCR
$594M
| $14.7M | 0.08% |
428,120
| – | – |
|
49
Spyre Therapeutics
SYRE
$1.02B
| $13.1M | 0.07% |
1,713,604
| – | – |
|
|
HOOK
50
DELISTED
HOOKIPA Pharma
HOOK
| $10.9M | 0.06% |
892,857
| – | – |
|